Immune Complex

مادة اعلانية

Latest Update: 17 Dec 2024 14:11 Abu Dhabi Time.

Market Status: Closed

MCCS

Immune Complex

3.76

QAR

-0.012

-0.32%

Open

3.78

Prev Close

3.78

PX_VOLUME

1,334,387

MARKET CAP (M)

DAY RANGE

3.75 - 3.78

52 WEEKS

3.51 - 4.72

Stock Statistics

Yearly Change

0.24%

Listed Shares (Million)

456.19

Earnings Multiple

9.06

Average 30-day trading volume

642,537.33

Price-to-book ratio

1.84

Earnings Per Share

-0.53

Previous Dividend Distribution

Dividend Yield

6.64%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,266.95	1,422.49	1,381.73	1,712.61	1,317.53
Gross Profit		218.10	267.28	252.96	323.92	212.97
Operating Income		63.98	86.28	77.83	189.78	71.67
Profit Margin		-0.39	2.77	2.03	-16.71	0.36

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Revenue	5,669.80	5,343.14
Gross Profit	1,005.45	866.82
Operating Income	421.92	214.81
Profit Margin	-4.29	-5.46

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		7,515.05	7,509.46	7,687.63	7,062.91	7,319.83
Total Liabilities		6,581.15	6,570.46	6,669.43	6,070.48	6,340.85
Total Equity		933.90	939.00	1,018.21	992.43	978.98

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Assets	7,062.91	7,278.31
Total Liabilities	6,070.48	6,383.41
Total Equity	992.43	894.90

Cash Flows Statements - Coming Soon

* In Million of Qatar Riyal

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.